Stem Cell Oversight Committee

The Stem Cell Oversight Committee reviews research applications involving human pluripotent stem cells that have been derived from and embryonic source and/or will be transferred into humans or non-human animals to ensure compliance with Chapter 12, Section F of the TCPS 2 (2014).

Terms of Reference
Stem cell research
Administrative resources

Members

Jay M. Baltz
Chair
Associate Director and Senior Scientist
Ottawa Hospital Research Institute

Harold Atkins
Physician, Blood and Marrow Transplant Program
The Ottawa Hospital

Alain Beaudet
CIHR President
Ex officio, non voting member

Tania Bubela
Assistant Professor
Department of Public Health Sciences, School of Public Health
University of Alberta

Tina Ceroni
Member of the Board of Directors of Clinical Trials Ontario (CTO)

Andrea Jurisicova
Investigator at Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and Associate Professor at the Departments of Obstetrics and Gynecology and Physiology at University of Toronto

Zubin Master
Assistant Professor,
Alden March Bioethics Institute,
Albany Medical College

Ubaka Ogbogu
Assistant Professor in the Faculties of Law and Pharmacy & Pharmaceutical Sciences and the Katz Research Fellow in Health Law and Science Policy at the University of Alberta

Barbara von Tigerstrom
Associate Professor
College of Law
University of Saskatchewan

Jacquetta Trasler
James McGill Professor in Pediatrics, Human Genetics and Pharmacology & Therapeutics at McGill University and Senior Scientist in the Child Health and Human Development Program at the Research Institute of the McGill University Health Centre

Sowmya Viswanathan
Affiliate Scientist at the Krembil Research Institute, University Health Network, and an Assistant Professor at the Institute of Biomaterials and Biomedical Engineering, University of Toronto

Amy Zarzeczny
Assistant Professor
University of Regina’s Johnson-Shoyama Graduate School of Public Policy (JSGS)

Date modified: